Linicin

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Linicin

Property Description
Active ingredient Dimethicone (Dimeticone)
Form Topical Lotion / Shampoo Preparation
Pharmacological class Pediculicide (Non-Insecticidal)
Common use Head Lice Infestation (Pediculosis capitis)
Origin Synthetic (Silicone Oil)

Linicin is an over-the-counter (OTC) pharmaceutical preparation classified as a pediculicide, with the primary purpose of managing head lice infestation (Pediculosis capitis). This product is a single active ingredient product designed for topical application to the hair and scalp. Linicin is available in several high-level dosage forms, including topical lotion and topical shampoo preparation. The medicine's general function is to effectively interrupt the parasite's life cycle, clearing the scalp of both mature lice and their eggs, known as nits, a common scenario for children and their close contacts.


Linicin's Non-Pesticidal Composition and Mechanism

The defining active ingredient in Linicin is dimethicone (dimeticone), which is chemically known as polydimethylsiloxane (PDMS) and is classified as a high-purity synthetic silicone oil. This composition classifies the preparation as a non-insecticidal treatment, placing it in a distinct category from traditional treatments that rely on neurotoxic chemicals, such as pyrethroids. Dimethicone acts against head lice (Pediculus humanus capitis) to eliminate the infestation.

Linicin works by a physical mode of action that leads to the rapid suffocation and immobilization of the parasites. Instead of acting as a chemical poison, the treatment physically seals the tiny respiratory openings (spiracles) of the louse, causing asphyxiation. The primary benefit of this physical mechanism is the near-elimination of the risk of the parasite developing resistance. This non-neurotoxic profile ensures the product remains effective even in areas where lice have developed resistance to conventional chemical treatments.

Regulatory References

  1. Dimethicone efficacy against head lice (NIH)
  2. Dimethicone and lice resistance

What side effects are possible with Linicin?

Possible Side Effects and Safety Information

The safety profile of Linicin, which contains the active ingredient dimethicone, is characterized by a minimal risk of systemic effects due to its non-absorbable, topical application. Adverse reactions are therefore primarily localized to the treatment area.


Adverse Reaction Scope

Classification Category Officially Documented Safety Statements
System-Organ Classes Primarily Skin and Subcutaneous Tissue Disorders (scalp irritation, itching, redness, flaking) and Eye Disorders (irritation, redness) if accidental contact occurs.
Frequency Classification Adverse reactions are classified as low incidence; clinical trial data for topical dimethicone formulations often report local irritation in less than 2% of participants.
Serious Adverse Reactions Regulatory documentation includes the potential for severe allergic reactions (hypersensitivity) to any component of the formulation, which can manifest as rash, hives, or swelling of the throat or face.

Population-Specific Safety Considerations and Restrictions

Regulatory guidance establishes specific constraints for the use of this pediculicide:

  • Pediatric Use: The product is not recommended for use in children younger than 2 years of age. This restriction is based on insufficient clinical safety data for this specific age group.
  • Flammability Warning: A critical, non-pharmacological restriction is that the product formulation is flammable. It must be kept away from heat, open flames, and lit cigarettes during application and until the hair is completely dry.
  • External Use: The product is strictly for external use only, and contact with the eyes and other mucous membranes must be avoided to prevent local irritation.

Overdose and Emergency Response

Linicin Overdose and when to seek help

The official regulatory profile for Linicin (Dimethicone) is shaped by its physical mechanism of action and low potential for systemic absorption. The guidance below reflects official documentation on overdose and emergency response.


Overdose Scope and Manifestations

Overdose Scope Regulatory Statement
Documented Manifestations No known recognised symptoms of overdose are documented following the topical application of the solution.
Physiological Risk Systemic effects are reported as unlikely as the solution is not expected to enter the bloodstream via the skin, and any minimal absorption would be rapidly eliminated.
Population Notes The instruction to keep the product out of reach of children is included because they are the population at greatest risk of accidental ingestion.

Emergency Actions

Emergency Action When Medical Help is Required
Required Action Get medical help or contact a Poison Control Center immediately in the event of accidental ingestion (swallowing the topical solution).
Urgent Symptoms Urgent medical assistance must also be sought if non-specific, severe symptoms such as passing out or trouble breathing are observed following accidental ingestion.

Management Notes

Official regulatory statements confirm that no specific antidote is known for this product. Treatment for any symptomatic presentation is therefore classified as symptomatic and supportive. No special procedures are generally needed, though continuous medical monitoring may be required following the ingestion of the solution.

Therapeutic Uses of Linicin

What Linicin Treats: Main Uses and Benefits

Linicin is applied in contexts marked by the presence of head lice and their eggs (nits), and is commonly used to help manage the external parasitic condition of pediculosis. Infestation is identified by the presence of a live louse or nymph, and the condition is characterized by symptoms related to physical discomfort. This treatment is relevant for situations requiring supportive symptom management and is commonly used to help with the elimination of the parasites.

Linicin may be part of symptomatic management applied in addressing the underlying infestation and symptoms. It helps with the elimination of the parasites and is relevant for easing the distressing symptomatic cluster of physical discomfort and scalp irritation that is commonly associated with the presence and activity of the lice. Providing this symptomatic support contributes to easing the overall symptom load and may assist with maintaining comfort during symptomatic phases.

“This medication is applied across therapeutic domains where additional symptomatic support is needed, primarily focusing on managing the visible infestation and resulting skin discomfort.”

Quick Fact: Relief for Itching and Irritation

The symptomatic relief offered by Linicin may assist with maintaining comfort and supports patients during episodes of heightened discomfort caused by head lice.

Eligibility and Restrictions for Use

Linicin’s eligibility profile is based strictly on the official population rules defined by governmental regulatory documents.

Eligibility Scope

The most important constraint is hypersensitivity: the medicine is formally contraindicated in patients with a known allergy to the active ingredient, Dimethicone, or to any other ingredient in the specific formulation. No specific restrictions related to major organ function, such as hepatic or renal impairment, are detailed in the official labeling.

Age-Related Eligibility Rules

Use is generally established for adults and older adults. For children, eligibility is defined by minimum age thresholds which vary by regulatory approval. Some documents permit use for children aged six months and above, while others restrict use to children aged two years and up. Children under six months must only be treated under medical supervision, while use in children under two years may be restricted or not recommended due to a lack of specific clinical experience in that age group.

Pregnancy and Lactation Status

Official guidance for pregnancy and breastfeeding is conditional and varies between regulatory agencies. Some documents state the product may be used as there is no data suggesting a contraindication. Conversely, other regulatory documents state the product is not recommended for these groups due to a lack of clinical experience and established safety data.

What should I know about interactions with other medicines?

Interaction Map: Interactions with other medicines and products — official regulatory information for Linicin

Interaction Scope

Official Regulatory Documentation Findings
Medicinal product categories with documented interactions None documented in regulatory sources.
Specific interacting medicines (if explicitly listed) None explicitly listed in regulatory interaction sections.
Mechanistic basis of interactions (only if stated in label) No systemic pharmacokinetic or pharmacodynamic mechanisms of interaction are documented. The regulatory profile is based on the product's physical mode of action and minimal systemic availability.
Timing-based interaction rules (if applicable) None documented. Official labels do not impose mandatory time separation requirements for co-administration.
Population-specific interaction notes (if applicable) None documented. Regulatory sources do not specify cautions regarding interaction relevance or severity in specific populations.
Interaction-related restrictions None documented. There are no explicitly stated regulatory restrictions related to systemic drug–drug interactions.

Interaction Classifications (High-Level)

Official Regulatory Documentation Findings
Interaction severity classification (as defined in official documents) Clinically non-significant systemic risk.
Regulatory basis (EMA / FDA / etc.) Information is consistent across multiple regulatory authorities, including the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA) regulatory monographs for dimethicone-based treatments.
Interaction-context constraints (as defined in official documents) The regulatory assessment of non-interaction is contingent on the product’s topical route of administration and the resulting lack of systemic absorption.

Resulting Interaction Structure

Official interaction statements:

  • The product is not associated with systemic drug–drug interactions.
  • Formal interaction studies were not deemed necessary due to the active ingredient's minimal or negligible systemic absorption following topical application.
  • No specific medicinal products, food, alcohol, or herbal products are documented to alter the official regulatory profile of the treatment.

Connection to the overall interaction profile (2–4 sentences): The regulatory interaction profile for Linicin is defined by its classification as a non-systemic product, which results in a lack of documented clinically significant systemic interactions. Official government documents confirm that no systemic pharmacokinetic or pharmacodynamic interactions are expected or described in the prescribing information. This structure means regulatory bodies have not imposed any formal restrictions, contraindications, or timing rules based on systemic drug interactions.

Mechanism of Action

How Linicin Works

Linicin products, containing dimethicone, operate through a physical mechanism of action, resulting in the functional inhibition of the essential life systems of head lice and nits.


Physical Pathway Interference: Inhibiting Respiration and Osmoregulation

The treatment acts within the mechanistic domain of physical pathway interference, where the high-viscosity silicone fluid completely coats the louse's exoskeleton. It quickly penetrates the spiracles—the external openings to the respiratory system—and the entire tracheal network. This initiates a mechanistic cascade leading to the complete physical blockage of air exchange. The process rapidly and simultaneously shuts down the respiratory and osmoregulatory systems, resulting in the irreversible inhibition of oxygen uptake and cellular water balance across all life stages.


Target Insensitivity: Independence from Biochemical Pathways

The mechanism engages a key regulatory concept known as target insensitivity. The product acts purely through physical means—sealing the outer structure—and does not rely on binding to or inhibiting a specific receptor or enzyme. The absence of a specific biochemical target means the mechanism is not subject to target site mutation or metabolic detoxification pathways, which provides independence from typical genetic evasion processes.

Dosage and Administration Information

How to Use Linicin: Administration Overview

The administration of Linicin, a dimethicone-based pediculicide, follows a standardized two-step protocol to ensure the successful elimination of head lice and nits. These instructions define the required application method, dosage schedule, and procedural steps.


Administration Protocol

Feature Instruction Detail
Route of Administration Topical application to the hair and scalp, for external use only.
Dosing Principle Apply a sufficient volume of the solution or lotion to ensure the entire hair and scalp are completely saturated.
Frequency and Schedule One initial application, followed by a repeat treatment after 7 to 10 days.
Exposure Time Leave the product on the hair for the minimum time specified on the label (e.g., 15 minutes, 30 minutes, or 8 hours/overnight, depending on formulation).

Required Procedural Steps and Constraints

Proper use requires specific steps to ensure the physical coating of the parasites, which is essential for the product’s effectiveness:

  1. Preparation: Apply the product to dry hair and thoroughly massage it into the scalp and hair, paying close attention to the areas behind the ears and the nape of the neck.
  2. Removal: After the required exposure time, thoroughly wash the hair with a standard shampoo. Recommended steps include first applying shampoo without water to help emulsify the oily solution before rinsing.
  3. Combing: A fine-toothed lice comb is used on the wet hair following the wash to physically remove the dead lice and nits.

Population Rules: The product is indicated for use in children from 6 months of age and over. No specific dose adjustment is needed for pregnant or breastfeeding women due to the negligible systemic absorption. The product also carries a flammability warning, requiring it to be kept away from heat sources or naked flames until it is fully rinsed out.

Recent Clinical Evidence

Research Evidence: Overview of Studies for Linicin (Dimethicone)

This overview summarizes the available clinical research on topical products containing dimethicone. The goal is to describe the types of studies that have been conducted and to outline what the research has explored, while maintaining neutral, non-advisory language.


Evidence for Use in Head Lice Infestation (Pediculosis capitis)

The core research for dimethicone formulations was evaluated in the context of head lice infestation, a condition involving live mobile parasites and their eggs (nits). The study landscape includes multiple Randomized Controlled Trials (RCTs) and comprehensive Systematic Reviews. These studies measured the outcome related to the absence of live lice and nits from the hair and scalp.

Researchers studied various dimethicone products in short-term trials, primarily involving school-age children who had confirmed infestations. These studies measured the proportion of participants documented as free from lice and viable eggs at specific check-up times, usually within one or two weeks after treatment.

Comparative Studies Against Other Pediculicides

Research examined dimethicone-based treatments against other methods available for head lice. This is relevant in settings where studies have explored the effect of dimethicone in study populations where conventional insecticide treatments were also evaluated. Studies examined the differences in measured clearance rates when dimethicone was compared directly against both conventional insecticide-based products and other non-insecticidal products in clinical research settings.

Long-Term Research and Follow-up Durations

The typical focus of the primary clinical assessments has been on short-term follow-up periods. The most critical assessments in these studies were conducted within the 7 to 14 day window following the recommended second treatment application. Long-term effects are not fully established, and there is limited information in the regulatory research record regarding outcomes that track participants for months after the initial treatment.

Quality of Evidence and Areas of Uncertainty

The overall research exploring dimethicone in the context of head lice is primarily derived from clinical trials, including RCTs. Research highlights that evidence quality varies across studies due to differences in the concentration of the active ingredient and product vehicles used. The results apply only to the populations studied and the specific conditions under which the research was conducted.

Key Studies & References

  1. Dimeticone-Based Pediculicides: A Physical Approach to Eradicate Head Lice (Systematic Review/Efficacy Overview)
  2. Head lice infestations: A clinical update (Canadian Paediatric Society Guideline)

Frequently Asked Questions (FAQ)

Common questions about Linicin (FAQ)


Q: Why is a repeat treatment needed with Linicin, and when should it be done?

A: According to official administration guidelines, a second treatment is a required step that must be performed 7 to 10 days after the initial application. This schedule is intended to address any newly hatched lice, called nymphs, that may have survived the first treatment while still inside the egg (nit).


Q: Are there any known issues with using Linicin if someone has asthma or eczema?

A: Regulatory documents for pediculicides suggest consulting a healthcare professional before use if there are known allergies to ingredients like ragweed. This warning is in place because, for some treatments, contact may potentially cause breathing difficulties or trigger an asthmatic reaction.


Q: Does the efficacy of Linicin depend on the length or thickness of the hair?

A: The effectiveness of the product depends on completely coating the parasites, which requires full saturation of the hair and scalp from root to tip. Official application guidance emphasizes that a sufficient volume of the product should be applied, which may mean adjusting the amount used based on hair length or thickness.


Q: How much product is typically needed for very long or very thick hair?

A: Official guidelines indicate that the amount needed is based on achieving complete saturation of the hair and scalp, not a fixed volume. Users with long or very thick hair may need to use a larger amount of product, and sometimes a larger package size, to ensure every strand is fully covered.


Q: What is the difference between Linicin Lotion and Linicin Shampoo?

A: Linicin is available in different pharmaceutical forms, specifically a topical lotion and a topical shampoo preparation. These different forms may vary in their physical consistency, application procedure, and the required length of exposure time (e.g., minutes versus overnight).


Q: How can I ensure all the Linicin product is properly rinsed out of the hair?

A: Because Linicin is an oil-based solution, official instructions sometimes suggest applying a standard shampoo directly to the dry, treated hair first. This process can help emulsify the oil before adding water and rinsing completely to ensure proper removal.


Q: Are there any specific shampoo types that should be avoided when washing out Linicin?

A: The product label generally recommends washing the hair with a standard, non-conditioning shampoo to facilitate removal of the oily base after the required exposure time. Using a non-conditioning product is often preferred for the removal step.


Q: Are there different versions of Linicin, like a '15 min solution' or a 'Pure Power' version?

A: The active ingredient dimethicone is formulated into various products that have different viscosities and mandated exposure times. Depending on the specific formulation, the time required for the treatment to work can range from as little as 15 minutes to as long as 8 hours or overnight.


Q: Can Linicin be used for preventative purposes, or only for an active infestation?

A: According to regulatory and public health guidance, Linicin is classified as a pediculicide and is indicated for the treatment of active head lice infestations only. Treatment for individuals who are not infected is considered unnecessary and ineffective.


Q: Is it necessary to use the fine-toothed comb included with some Linicin packages?

A: Regulatory guidance indicates that the use of a fine-toothed lice/nit comb on damp hair is a required step for treatment success. This physical removal step is necessary to clear the hair of all dead lice and eggs (nits) after the product has been rinsed out.


Q: Can Linicin products be used on body lice or pubic lice as well as head lice?

A: While the product is most commonly indicated for the treatment of head lice (Pediculosis capitis), the FDA’s Monograph for pediculicides includes indications for the treatment of head, pubic (crab), and body lice.


Q: Is it possible for a head lice infestation to return immediately after using Linicin?

A: Official labeling notes that an infestation may appear to return due to factors such as incomplete application (insufficient saturation), the hatching of a small number of surviving eggs, or quick re-infestation from close contact with untreated individuals.


Q: How do I know if the Linicin treatment was successful?

A: Treatment success is evaluated by the absence of live mobile lice on the hair and scalp after the required treatment course. This check should be performed after the recommended second application.


Q: Can using too much Linicin cause any additional side effects?

A: Because the product is non-systemic, serious internal effects are not expected; however, using excessive amounts may increase the likelihood of localized adverse reactions, such as mild irritation, redness, or itching of the scalp.


Q: Do I need to wash all bedding and clothing after using Linicin?

A: Public health guidance recommends decontaminating items like headwear, bedding, and towels that have been in recent contact with the infected person. Decontamination may be accomplished by washing items at high temperatures (e.g., 60 C) or by isolating them in a sealed plastic bag.


Q: Are there different warnings for the Linicin Lotion versus the Shampoo formulation?

A: Warnings and required procedures are often formulation-specific. For example, a product that requires a longer exposure time may have stricter guidance on keeping the treated hair away from heat and open flames until it is completely rinsed out.


Q: How does the mechanical way Linicin works compare to older chemical treatments?

A: Linicin works by a non-insecticidal, physical mechanism where it seals the lice’s respiratory openings, leading to suffocation. This action is chemically distinct from older treatments, such as those containing permethrin, which function as neurotoxins (nerve poisons).


Q: Is it normal for a small number of baby lice to appear a few days after the first treatment?

A: The second treatment is required after 7 to 10 days to kill any newly hatched lice (nymphs) that may appear in this interval. Finding newly hatched lice before the second treatment highlights the importance of the scheduled repeat application to complete the treatment course.


Q: Why is it important to treat only those who show signs of live head lice?

A: Regulatory guidance indicates that treatment should be focused only on individuals who show evidence of live head lice or live nits, as treating non-infected individuals is deemed unnecessary and should be avoided.


Q: Can you use a regular hairbrush or comb immediately after rinsing out Linicin?

A: The official procedure calls for the use of the fine-toothed lice comb on damp hair immediately after rinsing out the product to assist in the removal of dead lice and nits. This is a required procedural step.

How should Linicin be stored and disposed of?

How to Store and Dispose of Linicin?

The storage and disposal of Linicin (Dimethicone topical preparations) must strictly follow the requirements documented in official regulatory labeling.


Storage and Handling

Requirement Official Instruction
Temperature Does not require any special temperature storage conditions.
Protection Must be stored to protect the contents from light.
Packaging Keep in the original container to maintain light protection.
Child Safety Must be kept out of the sight and reach of children.

️ Disposal Instructions

Any unused product or waste material associated with Linicin must be disposed of in accordance with local requirements. Official documents require deferring to regional guidelines for safe pharmaceutical waste handling.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Linicin found in:

A-Z Index: